Trevi Therapeutics
TRVI----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Trevi Therapeutics(TRVI) predict that the EBIT is -14.91 M (-30.01%), Miss estimate;the EPS is -0.09 (+0%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.01B30.01%
-0.01B5.98%
-0.00B24.03%
EPSMiss expectations
-0.09--
-0.072219.76%
-0.017819.76%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf